IM Cannabis Corp. (IMCC)
NASDAQ: IMCC
· Real-Time Price · USD
2.60
0.03 (1.17%)
At close: Aug 14, 2025, 3:59 PM
2.68
3.08%
After-hours: Aug 14, 2025, 07:58 PM EDT
Company Description
IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel, Germany, and Canada.
It offers cannabis flowers and strain specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, and pressed hash offerings under the WAGNERS and Highland Grow brands.
The company serves medical patients and adult-use recreational consumers.
IM Cannabis Corp. is headquartered in Tel Aviv-Yafo, Israel.
IM Cannabis Corp.
| Country | IL |
| IPO Date | May 20, 2020 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 95 |
| CEO | Oren Shuster |
Contact Details
Address: Kibbutz Glil Yam Tel Aviv, IL | |
| Website | https://www.imcannabis.com |
Stock Details
| Ticker Symbol | IMCC |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001792030 |
| CUSIP Number | 44969Q208 |
| ISIN Number | CA44969Q4060 |
| Employer ID | 00-0000000 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Eyal Fisher | Chief Executive Officer of the IMC Holdings |
| Oren Shuster | Executive Chairman & Chief Executive Officer |
| Richard Balla | Chief Executive Officer of Adjupharm |
| Uri Birenberg | Chief Financial Officer |
| Advocate Michal Lebovitz Nissimov | General Counsel & Secretary |
| Anna Taranko | Director Investor & Public Relations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 13, 2025 | 6-K | Filing |
| Aug 13, 2025 | F-3 | Filing |
| Aug 12, 2025 | 6-K | Filing |
| Aug 04, 2025 | 6-K | Filing |
| Jul 31, 2025 | 6-K | Filing |
| Jul 11, 2025 | 6-K | Filing |
| Jul 09, 2025 | 6-K | Filing |
| Jul 01, 2025 | 6-K | Filing |
| Jun 26, 2025 | F-3 | Filing |
| May 28, 2025 | 6-K | Filing |